Lipid Screening in Children.

  title={Lipid Screening in Children.},
  author={Stephen R. Daniels},
  journal={Journal of the American College of Cardiology},
  volume={66 11},
  • S. Daniels
  • Published 15 September 2015
  • Medicine
  • Journal of the American College of Cardiology
Screening for lipid disorders in childhood and adolescence has been controversial. Although it is well documented that atherosclerotic cardiovascular disease is the number 1 cause of death in the United States and that elevated cholesterol, particularly low-density lipoprotein cholesterol (LDL-C), 
Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
FH was confirmed in almost half of the referred children, detected through the universal screening for hypercholesterolemia, and one parent had highly probable FH.
Universal Lipid Screening in 9- to 11-Year-Olds Before and After 2011 Guidelines.
Utah clinicians rarely follow guidelines for universal lipid screening of children aged 9 to 11, which represents a missed opportunity to identify children at risk for early-onset cardiovascular disease.
Dyslipidemia Screening of 9- to 11-Year-Olds at Well-Child Visits by Utah Pediatricians
In 2011, an expert National Institutes of Health panel published the “Integrated Guidelines for CV Health and Risk Reduction in Children and Adolescents,” which recommended screening all children
Beyond cascade screening: detection of familial hypercholesterolaemia at childhood immunization and other strategies
Combining universal and reverse cascade screening, complemented by opportunistic identification of individuals in high-risk settings, use of laboratory alerts, and screening of electronic health records are likely to have a high yield in the detection of familial hypercholesterolaemia in the community.
Persistent High Non‐High‐Density Lipoprotein Cholesterol in Early Childhood: A Latent Class Growth Model Analysis
Patterns of non‐ HDL cholesterol are identified during early childhood, and family history of high cholesterol was associated most strongly with persistent high non‐HDL cholesterol.


Screening for Lipid Disorders in Children and Adolescents.
A healthy 12-year-old boy presents for a school physical and well visit. His family history reveals that his maternal grandfather had a heart attack at 75 years of age and that his 52-year-old father
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease
There is an urgent worldwide need for diagnostic screening together with early and aggressive treatment of this extremely high-risk condition, familial hypercholesterolaemia.
Familial hypercholesterolemia in the danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication.
The prevalence of familial hypercholesterolemia appears to be higher than commonly perceived in a general population of white Danish individuals, with at least half of affected subjects not receiving cholesterol-lowering medication.
Universal Screening for Familial Hypercholesterolemia in Children.
Most participants who were referred from a national database of universal screening results for hypercholesterolemia had genetically confirmed FH, and data for family history may not suffice for reliable identification of patients through selective and cascade screening.
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
The ACC and AHA have collaborated with the National Heart, Lung, and Blood Institute and stakeholder and professional organizations to develop guidelines, standards, and policies that promote optimal patient care and cardiovascular health.
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Harmon S. Jordan, ScD, Lev Nevo, MD, Janusz Wnek, PhD Jeffrey L. Anderson,MD, FACC, FAHA, Chair-Elect, Nancy M. Halperin, PhD.
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.
This document is a compilation of the current American College of Cardiology Foundation/American Heart Association (ACCF/AHA) practice guideline recommendations for atrial fibrillation (AF) from the
Update : a report from the American Heart Association
  • Circulation
  • 2015
Consensus Statement of the European Atherosclerosis Society